|
JP2014144011A
|
|
Means and methods for mediating protein interference
|
|
US2007066803A1
|
|
Method to control tumor progression and invasiveness
|
|
US2008057054A1
|
|
Modulation of Phagocytosis in Neurons
|
|
AU2005202773A1
|
|
Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a Homologous or heterologous environment
|
|
US2008171706A1
|
|
Anti-Adhesive Compounds to Prevent and Treat Bacterial Infections
|
|
NZ547730A
|
|
Influenza immunogen and vaccine
|
|
WO2004026331A1
|
|
Peptides inhibiting specific cleaving activities of presenilins
|
|
AU2003296309A1
|
|
Use of plag or plag-inhibitors to diagnose and/or treat disease
|
|
EP1508575A1
|
|
Novel leptin antagonist
|
|
WO2004005541A1
|
|
Diagnostic tests for the detection of peripheral neuropathy
|
|
EP1517704A1
|
|
Use of antibodies against flt-1 for the treatment of osteoporosis
|
|
EP1506300A2
|
|
Genes and uses thereof to modulate secondary metabolite biosynthesis
|
|
CN1662817A
|
|
Marker for measuring liver cirrhosis
|
|
WO03073105A2
|
|
Use of plag1 and plagl2 in cancer diagnosis and drug screening
|
|
CA2476965A1
|
|
Method of modulating e-cadherin mediated cell adhesion
|
|
EP1472356A2
|
|
Plant growth modulation by drl1 and other proteins of the elongator complex
|
|
EP1474450A2
|
|
A novel target to inhibit angiogenesis
|
|
EP1482975A2
|
|
Prevention of tissue adhesion
|
|
CA2472927A1
|
|
A novel splice variant of myd88 and uses thereof
|
|
CA2471645A1
|
|
Immunoconjugates useful for treatment of tumours
|
